Senators to Big Pharma: Add prices to ads or we'll do it for you by Eric Sagonowsky Monday, May 21, 2018 Don't dismiss Trump's move to put drug prices in DTC ads. Five senators wrote top execs urging them to do it voluntarily or face congressional action.
Inovio's early-stage HIV vaccine delivers lasting immune responses by Eric Sagonowsky Tuesday, May 15, 2018 Inovio's HIV vaccine is in early-stage development, but the company reported immune responses induced by the shot that lasted at least six months.
AstraZeneca's Fasenra ambitions take a hit with failed COPD test by Carly Helfand Friday, May 11, 2018 AZ was hoping its next-gen COPD med Fasenra could help it keep pace with GlaxoSmithKline, but the drug just failed to beat placebo in a phase 3 study.
Longtime GSK CFO Dingemans heads for the exit by Carly Helfand Wednesday, May 9, 2018 GSK CEO Emma Walmsley has hired more than a few new execs since taking the baton. And now, she’ll have the opportunity to fill another big slot.
GSK Consumer invites bids for media account—again by Beth Snyder Bulik Wednesday, May 9, 2018 The estimated $1 billion media account for GlaxoSmithKline Consumer Healthcare is in play again.
Boosted by China launch, Merck's Gardasil turns in a big Q1 by Eric Sagonowsky Tuesday, May 8, 2018 Merck's Gardasil rollout in China helped the vaccine franchise grow sales 24% in the first quarter.
Glaxo's Shingrix should chip in $600M this year, execs say by Eric Sagonowsky Monday, April 30, 2018 GSK's Shingrix carried high expectations, but it turns out that even those ambitious projections weren't high enough.
China grants speedy landmark nod for Merck's Gardasil 9 by Angus Liu Monday, April 30, 2018 Merck's previous Gardasil version is already on sale in China, and the new approval could further compress the only remaining breathing room for GSK’s Cervarix.
